Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Opposing Views
Are Hot Dogs Really at “High Risk” of Killing Kids?
Hot dogs are delicious. Especially if you don’t think too hard about what they’re made of. Kids love them. So do adults. With baseball’s spring…
Newsletter
BPA, NASA, and the Clean Air Act
This week, Oregon voted down a partial ban on Bisphenol A, or BPA. Climategate has renewed the American public’s curiosity about NASA’s role in collecting…
Opposing Views
Killing Health Care Competition With Antitrust
Comprehensive health reform now seems dead. But at a press conference last week, House Speaker Nancy Pelosi said that Democrats would pursue easier-to-pass incremental…
Opposing Views
Killing Health Care Competition with Antitrust
Comprehensive health reform now seems dead. But at a press conference last week, House Speaker Nancy Pelosi said that Democrats would pursue easier-to-pass incremental…
Opposing Views
Rats, Humans and the Risks of BPA
Cheers to the Journal for your editorial "Baby Bottle Red Alert" (Jan. 30) on bisphenol A. On Jan. 27 the Cascade Policy…
News Release
Regulating Industry-Funded Science Could Harm Patient Safety, Report Finds
Regulating Industry-Funded Science Could Harm Patient Safety Study Finds Corporate Funding Tends to Incentivize Appropriate Behavior Washington, D.C., Feb. 4, 2010…